Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Emi Ono und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Pseudomonas alcaligenes, Pseudomonas Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, the Japan Agency for Medical Research and Developmen, Institute for Fermentation.
Abstract (Originalsprache)
Introduction
The emergence of carbapenem-resistant Pseudomonas species producing metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type MBL was firstly detected in 1991 in Japan. Since then, it has become one of the most prevalent types of MBLs. Hypothesis/Gap statement. Avirulent species of Pseudomonas , such as Pseudomonas alcaligenes , function as reservoirs of drug resistance-associated genes encoding carbapenemases in clinical settings. Methodology. Active surveillance for carbapenem-resistant Gram-negative pathogens was conducted in 2019 at a hospital in Tokyo, Japan. Of the 543 samples screened for carbapenem-resistant isolates, 2 were species of Pseudomonas . One was from a stool sample from a medical staff member, and the other was from a stool sample from a hospitalized patient.
Results
Whole-genome sequencing showed that the former isolate was a strain of P. alcaligenes , and the latter was a strain of Pseudomonas paralcaligenes , a species close to P. alcaligenes . Both isolates were resistant to all carbapenems and harboured bla IMP-1 genes encoding IMP-1 MBL, which conferred resistance to carbapenems. The bla IMP-1 genes of P. alcaligenes and P. paralcaligenes were located on the plasmids, pMRCP2, 323125 bp in size, and pMRCP1333, 16592 bp in size, respectively. The sequence of 82 % of pMRCP2 was 92 % similar to the sequence of a plasmid of P. aeruginosa PA83, whereas the sequence of 79 % of pMRCP1333 was >95 % similar to the sequence of a plasmid of Achromobacter xylosoxidans FDAARGOS 162. The genomic environments surrounding the bla IMP-1 of pMRCP2 and pMRCP1333 differed completely from each other.
Conclusions
These results indicate that the two isolates acquired bla IMP-1 from different sources and that P. alcaligenes and P. paralcaligenes function as vectors and reservoirs of carbapenem-resistant genes in hospitals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
- Japanese Red Cross Musashino Hospital, Tokyo, Japan.
- Department of Microbiome Research, Juntendo University School of Medicine, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- the Japan Agency for Medical Research and Developmen
- Institute for Fermentation
Zitieren
APA
Ono, E., Tohya, M., Tada, T., Hishinuma, T., Watanabe, S., Kuwahara-Arai, K., & Kirikae, T. (2023). Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001684
Vancouver
Ono E, Tohya M, Tada T, Hishinuma T, Watanabe S, Kuwahara-Arai K, et al. Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001684
BibTeX
@article{Ono2023,
author = {Ono, Emi and Tohya, Mari and Tada, Tatsuya and Hishinuma, Tomomi and Watanabe, Shin and Kuwahara-Arai, Kyoko and Kirikae, Teruo},
title = {Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001684}
}
EUVIMED